Viridian Therapeutics Inc (VRDN)

NASDAQ · Biotechnology

23.54
+0.45 (+1.95%)
Updated Aug 18, 4:16 PM ET
AI Rating
Buy
Overall Score
72
Trend
75
Momentum
88
Risk
46

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Viridian Therapeutics Inc is trading at $23.54, up 1.95% on the session. The 50 day average sits at $18.94 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 61.5, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $18.40 with resistance near $23.83, so that band frames the current range. Average daily movement is roughly $0.95, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 72 out of 100 combines a trend score of 75, momentum of 88 and a risk score of 46.

Technical indicators

RSI (14)
61.5
strong
MACD
1.076
bullish crossover
SMA 20
20.68
SMA 50
18.94
SMA 200
--
unknown
ATR (14)
0.95
avg daily range
Support
18.40
Resistance
23.83
Volume vs 20d
0.56x
below average
Volatility
49.4%
annualised
1 month
+22.46%
3 months
+26.68%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.